E coli toxin colibactin flagged to MPs as prime suspect in under-50 bowel cancer rise
A gut toxin made by some E coli bacteria is the leading explanation for soaring early onset bowel cancer, MPs on the Commons science and technology committee heard. Oxford's Dr Karl Smith-Byrne said known risks like obesity, smoking and alcohol only account for about half of cases, and he is a survivor of the disease himself.
- Original source: theguardian.com.
- The source published it on Nov 18, 2026 at 5:21 PM.
- No second outlet has reported it yet. Treat it as a single-source claim.
Dr Karl Smith-Byrne, a senior molecular epidemiologist at the University of Oxford, told the Commons science and technology committee that colibactin — a toxin produced by some variants of E coli living in the gut — is the frontrunner. Asked about the cause of the rise, he said: “That's probably the leading explanation at the moment.” Known risk factors such as obesity, smoking and alcohol explain only about half of colorectal cancers doctors diagnose, and he told MPs he did not find it “plausible” that the surge could be entirely down to risks researchers already knew about.
The scale of the problem is stark: early onset bowel cancer cases have doubled in many countries over the past two decades. Bowel cancer is still the third most common cancer worldwide, accounting for roughly one in 10 of all cases, but diagnoses are climbing steeply in younger people. Colibactin's fingerprints showed up last year when scientists found hallmark mutations caused by the toxin were three times more common in tumours from people under 40 than in those from people over 70.
Prof Mike Stratton of the Sanger Institute, who was not at the hearing, has found that colibactin causes mutations in some children but not others, with signs appearing as early as infancy. By age 10, affected children can carry a “mutational burden” similar to that of a 50-year-old. Smith-Byrne said that if the toxin is causing mutations, it is doing so “at a sensitive period earlier in life,” giving a person's colon or rectum “a head start” toward cancer.
Prof Elio Riboli, a cancer epidemiologist at Imperial College London, told the committee the toxin looks like a modern arrival. “This colibactin is essentially found in people born after 1960,” he said. “Something has happened in the E coli bacteria … There must have been a mutation, and there is a new bacteria.”
Prof Helen Coleman, a cancer epidemiologist at Queen's University Belfast, called colibactin “the first new clue that we've had in quite some time,” while stressing its role is still under investigation. She suggested the trigger could sit far earlier than diagnosis: “It could be something you were exposed to in very early childhood, possibly even in the prenatal period, and that makes it very difficult to study.”
Riboli argued the fastest gains would come from acting on what is already known. Drinking and smoking are falling in the UK and US, but obesity is rising and physical activity is declining. “We could prevent about 60% of the cancers occurring now, but we are not applying in society what we know,” he said.
TopicsE. coli · Karl Smith-Byrne · University of Oxford · Mike Stratton · Sanger Institute · Elio Riboli · Helen Coleman · Queen's University Belfast
Source: theguardian.com
Written by AI from verified reporting.
More stories
- Health & science rarecancernews.com 2 viewsEU approves Rasonque for previously treated metastatic pancreatic cancer
- Health & science medicalxpress.com Caught by @breakwater128 2 viewsFive-Day Antiviral Infusion Safe for Long COVID, ERASE Trial Finds
- Health & science dailycoffeenews.com 2 viewsFDA Pullplug on Methylene Chloride Use, Decaf Ban Fight Continues
- Health & science wam.ae 2 viewsUAE drug regulator: no medical ads without approval, influencer promos banned

